Speakers

Ursula Matulonis, Bradley J. Monk, Kathleen Moore

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Family Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Dr. Matulonis is Medical Director and Disease Center Leader of the Medical Gynecologic Oncology Program at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School in Boston, Massachusetts. She also is the interim Director of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. Her research focuses on developing new targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how that can lead to rationale drug development and selection.

Dr. Matulonis is Principal Investigator (PI) of several therapeutic clinical trials and translational studies for ovarian cancer. She is the overall PI on a Program Project Development Grant funded by the Ovarian Cancer Research Foundation entitled “Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy.” She is the PI on the project “Genetic Similarities between Serous Ovarian Cancer and Triple-Negative Breast Cancer” funded by the Breast Cancer Research Foundation. Dr. Matulonis serves on the National Comprehensive Cancer Network Recommendation and Guideline Committee for ovarian cancer, the Massachusetts Ovarian Cancer Task Force, the Gynecologic Oncology Group Ovarian Committee, the National Cancer Institute Ovarian Cancer Task Force, the Scientific Advisory Board of the Ovarian Cancer Research Foundation, the Scientific Board of the Clearity Foundation, and is Medical Director and a board member for the non-profit organization, Ovations for the Cure. She is a recipient of the Dennis Thompson Compassionate Care Scholar award, the Lee M. Nadler “Extra Mile” Award, the Leonard P. Zakim Patient Advocacy Award, and the Susan M. Love Award from Fenway Health.

After receiving her medical degree from Albany Medical College in Albany, New York, she completed an internship and residency at the University of Pittsburgh in Pittsburgh, Pennsylvania, followed by a medical oncology fellowship at the Dana-Farber Cancer Institute.

Back to top

Bradley J. Monk, MD, FACS, FACOG

Professor
Arizona Oncology (US Oncology Network)
US Oncology Medical Director of Gynecologic Oncology Research
University of Arizona College of Medicine–Phoenix
Creighton University School of Medicine at St. Joseph’s Hospital
Phoenix, Arizona

Dr. Monk graduated at the top of his class from the University of Arizona College of Medicine in Tucson, Arizona, in 1988, and completed a residency in Obstetrics and Gynecology at the University of California in Los Angeles, California, in 1992. Between 1988 and 1995, he was the recipient of three fellowships in Medical Genetics and Gynecologic Oncology. In 1995, Dr. Monk was appointed Director of Gynecologic Oncology at Texas Tech University Health Services Center in Lubbock, Texas; and from 1998 to 2010, he was Associate Professor with Tenure of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, at the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center and Director of Research in the Department of Obstetrics and Gynecology in Irvine, California. Dr. Monk then was appointed Director and Professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. In 2016, he became a member of Arizona Oncology and part of the US Oncology Network and continues to practice in Phoenix. Most recently, he has been appointed the US Oncology Medical Director of Gynecologic Oncology Research. Dr. Monk also is a Professor on the Clinical Scholar Track at the University of Arizona College of Medicine in Phoenix and works at Arizona Oncology. He has been named one of Arizona’s “Top Doctors” by PHOENIX magazine 5 years in a row beginning in 2012.

Back to top

Kathleen Moore, MD, MS

The Virginia Kerley Cade Endowed Chair in Cancer Development
Associate Director for Clinical Research
Director, Oklahoma TSET Phase I Program
Medical Director, Clinical Trials Office
Stephenson Cancer Center
Associate Professor, Section of Gynecologic Oncology
Director, Gynecologic Oncology Fellowship
Department of Obstetrics and Gynecology
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma

Kathleen Moore, MD is an Associate Professor in the section of Gynecologic Oncology and serves as the Director of the Oklahoma TSET Phase I Clinical Trials Program, the state’s only phase I clinical trials program. She is the Jim and Christy Everest Endowed Chair in Cancer Research, as well as the Director of the Gynecologic Oncology Fellowship Program. She also serves as the Associate Director of Clinical Research and Medical Director of the Clinical Trials Office for the Stephenson Cancer Center.

Dr. Moore has published more than 200 peer-reviewed publications and serves on the editorial board for four academic publications. She has a clinical research interest in drug development and phase I trials.

She attended medical school at the University of Washington School of Medicine and completed her residency in Obstetrics and Gynecology at the University Health Center of Pittsburgh. Dr. Moore completed a fellowship in Gynecologic Oncology at the University of Oklahoma Health Sciences Center while simultaneously earning a Master’s Degree in Epidemiology.

She is board certified in Obstetrics and Gynecology as well as Gynecologic Oncology and Hospice and Palliative Care.

Back to top